[1] Cann, R. O., Chen, C.-P. H., Gao, Q., Hanson, R. L., Hsieh, D., Li, J., Lin, D., Parsons, R. L., Pendri, Y., Nielsen, R. B., Nugent, W. A., Parker, W. L., Quinlan, S., Reising, N. P., Remy, B., Sausker, J., & Wang, X. (2012). Selection of an Enantioselective Process for the Preparation of a CGRP Receptor Inhibitor. Organic Process Research & Development, 16(12), 1953–1966.
https://doi.org/10.1021/op3003097 [2] Knoepfel, T., Nimsgern, P., Jacquier, S., Bourrel, M., Vangrevelinghe, E., Glatthar, R., Behnke, D., Alper, P. B., Michellys, P.-Y., Deane, J., Junt, T., Zipfel, G., Limonta, S., Hawtin, S., Andre, C., Boulay, T., Loetscher, P., Faller, M., Blank, J., … Betschart, C. (2020). Target-Based Identification and Optimization of 5‑Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay. Journal of Medicinal Chemistry, 63(15), 8276–8295.
https://doi.org/10.1021/acs.jmedchem.0c00130